Literature DB >> 25819177

The effect of transradial coronary catheterization on upper limb function.

Maarten A H van Leeuwen1, Nicolas M van Mieghem2, Mattie J Lenzen2, Ruud W Selles3, Mirjam F Hoefkens4, Felix Zijlstra2, Niels van Royen5.   

Abstract

OBJECTIVES: The aim of this study was to analyze the change of upper limb function when percutaneous coronary procedures were performed through the radial artery.
BACKGROUND: It is currently unknown if upper limb function is affected by transradial (TR) catheterization.
METHODS: Between January 2013 and February 2014, upper limb function was assessed in a total of 338 patients undergoing coronary catheterization in an ambulatory setting (85% radial approach, 15% femoral approach). Upper limb function was assessed with the self-reported shortened version of the Disabilities of Arm, Shoulder, and Hand questionnaire. The presence and severity of upper extremity cold intolerance was assessed with the self-reported Cold Intolerance Symptom Severity questionnaire. Both questionnaires were completed before the catheterization and at 30-day follow-up. Higher scores represent worse upper limb functionality or symptoms. The nonparametric Wilcoxon signed-rank test was used to assess the change of upper limb function and symptoms over time.
RESULTS: Upper limb function did not change significantly over time when catheterization was performed through the radial artery (p=0.06). The number of procedure-related extremity complaints that persisted during 30-day follow-up were not different between both access groups (TR access 10.5%, transfemoral access 11.5%; p=0.82). The upper extremity was not affected by cold intolerance after TR access at 30-day follow-up (p=0.91).
CONCLUSIONS: Upper limb function was not affected when coronary catheterizations and interventions were performed through the radial artery.
Copyright © 2015 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  PCI; catheterization; extremity problems; hand function; transradial

Mesh:

Year:  2015        PMID: 25819177     DOI: 10.1016/j.jcin.2014.10.025

Source DB:  PubMed          Journal:  JACC Cardiovasc Interv        ISSN: 1936-8798            Impact factor:   11.195


  7 in total

Review 1.  Radial Artery and Ulnar Artery Occlusions Following Coronary Procedures and the Impact of Anticoagulation: ARTEMIS (Radial and Ulnar ARTEry Occlusion Meta-AnalysIS) Systematic Review and Meta-Analysis.

Authors:  George Hahalis; Konstantinos Aznaouridis; Gregory Tsigkas; Periklis Davlouros; Ioanna Xanthopoulou; Nikolaos Koutsogiannis; Ioanna Koniari; Marianna Leopoulou; Olivier Costerousse; Dimitris Tousoulis; Olivier F Bertrand
Journal:  J Am Heart Assoc       Date:  2017-08-23       Impact factor: 5.501

2.  Predictive Value of the (Quick)DASH Tool for Upper Extremity Dysfunction Following Percutaneous Coronary Intervention.

Authors:  Eva Zwaan; Elena Cheung; Alexander IJsselmuiden; Carlo Holtzer; Ton Schreuders; Marcel Kofflard; Marco Alings; J Henk Coert
Journal:  Patient Relat Outcome Meas       Date:  2022-06-27

Review 3.  Neurovascular Complications of the Upper Extremity Following Cardiovascular Procedures.

Authors:  Bryan G Beutel; Scott D Lifchez; Eitan Melamed
Journal:  J Hand Microsurg       Date:  2016-07-01

4.  Upper-extremity dysfunction following transradial percutaneous procedures: an overlooked and disregarded complication?

Authors:  M E C J Hassell; J J Piek
Journal:  Neth Heart J       Date:  2015-11       Impact factor: 2.380

5.  The tricky charm of the radial access.

Authors:  A Azzano; P Vermeersch
Journal:  Neth Heart J       Date:  2015-11       Impact factor: 2.380

6.  Hand dysfunction after transradial artery catheterization for coronary procedures.

Authors:  Muhammad Ayyaz Ul Haq; Muhammad Rashid; Chun Shing Kwok; Chun Wai Wong; James Nolan; Mamas A Mamas
Journal:  World J Cardiol       Date:  2017-07-26

7.  Upper Extremity Function following Transradial Percutaneous Coronary Intervention: Results of the ARCUS Trial.

Authors:  Eva M Zwaan; Elena S Cheung; Alexander J J IJsselmuiden; Carlo A J Holtzer; Ton A R Schreuders; Marcel J M Kofflard; J Henk Coert
Journal:  J Interv Cardiol       Date:  2022-09-06       Impact factor: 1.776

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.